A Study to Assess the Immunogenicity and Safety of CSL's 2009 / 2010 Formulation of Enzira® Vaccine in Healthy Volunteers

NCT00888381 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Inactivated Influenza Vaccine (2009 / 2010 formulation)

Sponsor

Seqirus